Key Takeaways
- • Eight Montgomery County, Maryland companies received a combined $70.54 million in venture capital, seed, and other investments in October, according to PoPville.
- • Research & Development companies led investment activity with more than $58 million raised across biotechnology, drug discovery, and healthcare.
- • Rockville-based Kaigene raised $54.96 million in Series B venture funding from Loftyrock Investment and others, with a reported pre-money valuation of approximately $252.5 million.
- • Accufy Diagnostics (Rockville) raised $2 million in seed funding for ctDNA-based early cancer detection, while ColoWatch (Gaithersburg) raised $1.325 million in venture funding for virtual colonoscopy screening.
- • Bethesda-based Emerald Intel raised $3.3 million in seed funding for a market intelligence platform serving the cannabis and hemp industry; Rockville-based UgenticAI secured approximately $349,000 via equity crowdfunding.
Summary
Eight start-ups and early-growth companies in Montgomery County, Maryland, received a combined $70.54 million in venture capital, seed funding, and other investments during October, according to PoPville. The county, which the report describes as the third-largest biopharma hub in the nation, saw its Research & Development segment lead investment attraction with more than $58 million raised.
The largest transaction was Rockville-based Kaigene's $54.96 million Series B round, led by or including Loftyrock Investment and other investors. Kaigene is developing therapeutic antibodies for rare autoimmune diseases, including multiple sclerosis and lupus. The company's reported pre-money valuation following the round is approximately $252.5 million.
Other Research & Development companies included Rockville-based Accufy Diagnostics, which raised $2 million in seed funding to advance next-generation sequencing for early cancer detection using ultra-sensitive circulating tumor DNA (ctDNA) detection to monitor minimal residual disease. Gaithersburg-based ColoWatch raised $1.325 million in venture funding to expand access to colorectal cancer screening, which the American Cancer Society ranks as the second deadliest cancer in the United States, through virtual colonoscopy using three-dimensional imaging.
Outside life sciences, Bethesda-based Emerald Intel raised $3.3 million in seed funding for a market intelligence platform covering the cannabis and hemp industry, offering verified business profiles, decision-maker contacts, and regulatory information. Rockville-based UgenticAI secured approximately $349,000 through equity crowdfunding for a platform that acquires and scales artificial intelligence and SaaS companies.
The report characterizes the October activity as reflecting continued funding momentum across Montgomery County's biotechnology, healthcare, and technology sectors.
The largest transaction was Rockville-based Kaigene's $54.96 million Series B round, led by or including Loftyrock Investment and other investors. Kaigene is developing therapeutic antibodies for rare autoimmune diseases, including multiple sclerosis and lupus. The company's reported pre-money valuation following the round is approximately $252.5 million.
Other Research & Development companies included Rockville-based Accufy Diagnostics, which raised $2 million in seed funding to advance next-generation sequencing for early cancer detection using ultra-sensitive circulating tumor DNA (ctDNA) detection to monitor minimal residual disease. Gaithersburg-based ColoWatch raised $1.325 million in venture funding to expand access to colorectal cancer screening, which the American Cancer Society ranks as the second deadliest cancer in the United States, through virtual colonoscopy using three-dimensional imaging.
Outside life sciences, Bethesda-based Emerald Intel raised $3.3 million in seed funding for a market intelligence platform covering the cannabis and hemp industry, offering verified business profiles, decision-maker contacts, and regulatory information. Rockville-based UgenticAI secured approximately $349,000 through equity crowdfunding for a platform that acquires and scales artificial intelligence and SaaS companies.
The report characterizes the October activity as reflecting continued funding momentum across Montgomery County's biotechnology, healthcare, and technology sectors.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.